Trials / Completed
CompletedNCT01361815
Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)
A Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI) for Subjects With MDD Who Complete/ Discontinued the CTP-0001-00 Protocol
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Brainsway · Industry
- Sex
- All
- Age
- 22 Years – 68 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to explore the Tolerability and Safety of the H-Coil deep Transcranial Magnetic Stimulation (TMS) in combination with Serotonin Selective Reuptake Inhibitor (SSRI) for Subjects with Major Depression Disorder (MDD) who Complete/ Discontinued the Deep TMS Multicenter study for Subjects with Major Depression Disorder (MDD) (Protocol# CTP-0001-00).
Conditions
- Major Depressive Disorder, Recurrent, Unspecified
- Major Depressive Disorder, Single Episode, Unspecified
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | H-Coil Deep TMS in combination with SSRIs | The study group will receive DTMS treatment three times a week for four weeks in combination with SSRI medications. |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2011-05-27
- Last updated
- 2020-07-15
Locations
19 sites across 4 countries: United States, Canada, Germany, Israel
Source: ClinicalTrials.gov record NCT01361815. Inclusion in this directory is not an endorsement.